Search

EHA’s advocacy for hematology continues

The EHA Board has recently approved five position papers which formulate EHA’s key lobbying priorities:

Support for hematology research in Horizon 2020 (and future EU research funding programs)
Access to treatment for patients with blood disorders
EU collaboration to reduce the prices…

Read more

COVID-19 Expert opinions

Expert opinions for hematologists in COVID-19 crisis
COVID-19, caused by SARS-CoV-2, is expected to be a devastating infection in many patients with hematologic diseases.

Read more

EHA2022 Gallery

Thank you to the Faculty, delegates, and industry partners for contributing to the EHA2022 Hybrid Congress.

Read more

Two genes cooperate to trigger leukemia development

Congratulations to the international group of researchers led by HemaSphere Editor-in-Chief Prof.

Read more

EHA2024 gallery

Thank you to the esteemed faculty, delegates, and industry partners for their valuable contributions to the EHA2024 Hybrid Congress, which took place in Madrid and online from June 13–16.

Read more